Relevant bibliographies by topics / Global Burden of Disease (GBD) 2019

Contents

  1. Journal articles
  2. Books
  3. Book chapters
  4. Conference papers
  5. Reports

Academic literature on the topic 'Global Burden of Disease (GBD) 2019'

Author: Grafiati
Published: 7 June 2025
Last updated: 9 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Global Burden of Disease (GBD) 2019.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Global Burden of Disease (GBD) 2019"

1

Pandey, Achyut Raj, Meghnath Dhimal, Niraj Shrestha, et al. "Burden of Cardiovascular Diseases in Nepal from 1990 to 2019: The Global Burden of Disease Study, 2019." Global Health 2023 (June 19, 2023): 1–15. http://dx.doi.org/10.1155/2023/3700094.

Full text
Abstract:
Cardiovascular diseases (CVDs) have emerged as the leading cause of deaths worldwide in 2019. Globally, more than three-quarters of the total deaths due to CVDs occur in low- and middle-income countries like Nepal. Although increasing number of studies is available on the prevalence of CVDs, there is limited evidence presenting a complete picture on the burden of CVDs in Nepal. In this context, this study aims to provide comprehensive picture on the burden of CVDs in the country. This study is based on the Global Burden of Disease (GBD) study 2019, which is a multinational collaborative research covering 204 countries and territories across the world. The estimations made from the study are publicly available in the GBD Compare webpage operated by the Institute for Health Metrics and Evaluation (IHME), University of Washington. This article makes use of those data available on the GBD Compare page of IHME website to present the comprehensive picture of the burden of CVDs in Nepal. Overall, in 2019, there were an estimated 1,214,607 cases, 46,501 deaths, and 1,104,474 disability-adjusted life years (DALYs) due to CVDs in Nepal. The age-standardized mortality rates for CVDs witnessed a marginal reduction from 267.60 per 100,000 population in 1990 to 245.38 per 100,000 population in 2019. The proportion of deaths and DALYs attributable to CVDs increased from 9.77% to 24.04% and from 4.82% to 11.89%, respectively, between 1990 and 2019. Even though there are relatively stable rates of age-standardized prevalence, and mortality, the proportion of deaths and DALYs attributed to CVDs have risen sharply between 1990 and 2019. Besides implementing the preventive measures, the health system also needs to prepare itself for the delivery of long-term care of patients with CVDs which could have significant implications on resources and operations.
APA, Harvard, Vancouver, ISO, and other styles
2

Kocarnik, Jonathan M., Kelly Compton, Franny Dean, et al. "The global burden of 29 cancer groups from 2010 to 2019: A systematic analysis for the Global Burden of Disease study 2019." Journal of Clinical Oncology 39, no. 15_suppl (2021): 10577. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10577.

Full text
Abstract:
10577 Background: Cancer is a major cause of morbidity and mortality worldwide, and global efforts to reduce health loss from cancer require systematic estimates that can measure progress from national to global levels. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019), we examined global cancer burden in order to highlight areas where cancer burden is inequitably distributed and to inform cancer control efforts around the world. Methods: Using estimation methods from GBD 2019, we analyzed the incidence, mortality, years lived with disability, years of life lost (YLLs), and disability-adjusted life years (DALYs) for 29 cancer groups and 204 countries and territories from 2010 to 2019. Cancer burden was compared to health burden from other categories of diseases and injuries in the GBD. Results were assessed globally and by socio-demographic index (SDI), a summary measure of income per capita, average educational attainment, and total fertility rate. Point estimates and 95% Uncertainty Intervals (UIs) are reported. Results: There were 23.6 million (95% UI 22.2-24.9 million) incident cancer cases globally in 2019 (17.2 [15.9-18.5] million excluding non-melanoma skin cancer), and 10.0 (9.36-10.6) million cancer deaths. There were 250 (235-264) million DALYs globally due to cancer, 97% of which came from years of life lost. The leading five cancers by DALYs in 2019 were: tracheal, bronchus, and lung cancer (45.9 [42.3-49.3] million); colon and rectum cancer (24.3 [22.6-25.7] million); stomach cancer (22.2 [20.3-24.1] million); breast cancer (20.6 [19.0-22.2] million; and liver cancer (12.5 [11.4-13.7] million). Compared to other diseases and injuries in the GBD, cancer was responsible for the second-highest number of deaths, YLLs, and DALYs globally in 2019. These rankings of cancer burden differed by SDI quintile: cancer was the leading cause of absolute DALYs in high SDI countries but was ranked 10th in low SDI countries. From 2010-2019, the number of global cancer cases increased by 26.3% (20.3-32.3%), deaths by 20.9% (14.2-27.6%), and DALYs by 16.0% (9.29-22.8%). The largest annualized rate of change in absolute cases and deaths over this period occurred in the low and low-middle SDI quintiles. Conclusions: Cancer cases and deaths are growing globally, with the largest relative growth over the last decade occurring in low to middle SDI countries. Improvements in cancer prevention efforts and ensuring access to timely diagnosis and care will be necessary to make equitable progress in reducing the global burden of cancer.
APA, Harvard, Vancouver, ISO, and other styles
3

Franklin, Richard Charles, Amy E. Peden, Erin B. Hamilton, et al. "The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study." Injury Prevention 26, Supp 1 (2020): i83—i95. http://dx.doi.org/10.1136/injuryprev-2019-043484.

Full text
Abstract:
BackgroundDrowning is a leading cause of injury-related mortality globally. Unintentional drowning (International Classification of Diseases (ICD) 10 codes W65-74 and ICD9 E910) is one of the 30 mutually exclusive and collectively exhaustive causes of injury-related mortality in the Global Burden of Disease (GBD) study. This study’s objective is to describe unintentional drowning using GBD estimates from 1990 to 2017.MethodsUnintentional drowning from GBD 2017 was estimated for cause-specific mortality and years of life lost (YLLs), age, sex, country, region, Socio-demographic Index (SDI) quintile, and trends from 1990 to 2017. GBD 2017 used standard GBD methods for estimating mortality from drowning.ResultsGlobally, unintentional drowning mortality decreased by 44.5% between 1990 and 2017, from 531 956 (uncertainty interval (UI): 484 107 to 572 854) to 295 210 (284 493 to 306 187) deaths. Global age-standardised mortality rates decreased 57.4%, from 9.3 (8.5 to 10.0) in 1990 to 4.0 (3.8 to 4.1) per 100 000 per annum in 2017. Unintentional drowning-associated mortality was generally higher in children, males and in low-SDI to middle-SDI countries. China, India, Pakistan and Bangladesh accounted for 51.2% of all drowning deaths in 2017. Oceania was the region with the highest rate of age-standardised YLLs in 2017, with 45 434 (40 850 to 50 539) YLLs per 100 000 across both sexes.ConclusionsThere has been a decline in global drowning rates. This study shows that the decline was not consistent across countries. The results reinforce the need for continued and improved policy, prevention and research efforts, with a focus on low- and middle-income countries.
APA, Harvard, Vancouver, ISO, and other styles
4

Butarbutar, John CP, Pamela Basuki, Veli Sungono, Albert Riantho, and Kevin Fidiasrianto. "Burden of osteoarthritis in Indonesia: A Global Burden of Disease (GBD) study 2019." Narra J 4, no. 2 (2024): e884. http://dx.doi.org/10.52225/narra.v4i2.884.

Full text
Abstract:
Osteoarthritis (OA) is a complex and common condition, especially affecting the knees due to their weight-bearing role. Traditionally seen as a degenerative disease, OA is now understood to have both mechanical and inflammatory causes. Despite its increasing prevalence, there is limited data on OA in Indonesia, resulting in low awareness among clinicians and the public. The aim of this study was to describe the OA burden in Indonesia, focusing on its prevalence, incidence, and years lived with disability (YLD) from 1990 to 2019, using data from the Global Burden of Disease (GBD) study 2019. A descriptive cross-sectional study was conducted to examine the prevalence, incidence, and YLD of OA in Indonesia from the GBD study 2019. OA prevalence and YLD were compared to other countries according to similar social demographics and geographical proximity. OA YLD was also compared to the top causes of death and disability YLD in Indonesia. The study found that OA cases in Indonesia more than doubled from 1990 to 2019, with increases of 153.12% in males and 143.36% in females. Similar trends were observed for knee OA. The age-standardized prevalence rate in Indonesia increased by 10.03% in males and 8.42% in females, and these were higher compared to China, India, Singapore, and the global average. Younger people had a higher OA prevalence rate growth than older groups. The incidence rate for OA also rose significantly, with males seeing a 10.89% increase to 290 per 100,000 people and females with an 8.57% increase to 384 per 100,000 people. Despite lower overall burden rates compared to some countries, Indonesia experienced significant growth in YLD due to OA (12.16% in males and 9.65% in females) since 1990. Although OA was less burdensome than stroke, diabetes, low back pain, and chronic obstructive pulmonary disease (COPD), its YLD growth rate was higher. In conclusion, OA prevalence and incidence in Indonesia significantly increased from 1990 to 2019, with a notable rise among younger populations. OA had a higher YLD growth compared to several other major diseases in Indonesia, highlighting the need for early detection and preventive measures, particularly for the younger population.
APA, Harvard, Vancouver, ISO, and other styles
5

Salleh, Mohd Razali. "The Burden of Mental Illness: An Emerging Global Disaster." Journal of Clinical and Health Sciences 3, no. 1 (2018): 5. http://dx.doi.org/10.24191/jchs.v3i1.6150.

Full text
Abstract:
The global burden of disease (GBD) has shifted from communicable to non-communicable diseases, and from premature death to years live with disabilities (YLDs) over the past 30 years. Mental and substance use disorders constitute a major component in the scenario of the global health with a significant impact on the global burden of disease, especially in the developing countries. The 1990 GBD study listed depression as the fourth common cause of global burden of disease; while lower respiratory infections, diarrheal diseases and conditions arising during perinatal period are top in the list. In GBD 2000 study depressive disorders climbed to the third place, however still behind lower respiratory infections and diarrheal diseases. The subsequent 2010 GBD study ranked depression in the second place of the global disability burden, and are also considered as a major contributor to the burden of suicide and ischaemic heart disease. The WHO predicted that depressive disorders will be the leading cause of global burden in 2030.
APA, Harvard, Vancouver, ISO, and other styles
6

Dhimal, Meghnath, Francesco Chirico, Bihungum Bista, et al. "Impact of Air Pollution on Global Burden of Disease in 2019." Processes 9, no. 10 (2021): 1719. http://dx.doi.org/10.3390/pr9101719.

Full text
Abstract:
Air pollution consisting of ambient air pollution and household air pollution (HAP) threatens health globally. Air pollution aggravates the health of vulnerable people such as infants, children, women, and the elderly as well as people with chronic diseases such as cardiorespiratory illnesses, little social support, and poor access to medical services. This study is aimed to estimate the impact of air pollution on global burden of disease (GBD). We extracted data about mortality and disability adjusted life years (DALYs) attributable to air pollution from 1990 to 2019. The extracted data were then organized and edited into a usable format using STATA version 15. Furthermore, we also estimated the impacts for three categories based on their socio-demographic index (SDI) as calculated by GBD study. The impacts of air pollution on overall burden of disease by SDI, gender, type of pollution, and type of disease is estimated and their trends over the period of 1990 to 2019 are presented. The attributable burden of ambient air pollution is increasing over the years while attributable burden of HAP is declining over the years, globally. The findings of this study will be useful for evidence-based planning for prevention and control of air pollution and reduction of burden of disease from air pollution at global, regional, and national levels.
APA, Harvard, Vancouver, ISO, and other styles
7

James, Spencer L., Chris D. Castle, Zachary V. Dingels, et al. "Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017." Injury Prevention 26, Supp 1 (2020): i96—i114. http://dx.doi.org/10.1136/injuryprev-2019-043494.

Full text
Abstract:
BackgroundPast research in population health trends has shown that injuries form a substantial burden of population health loss. Regular updates to injury burden assessments are critical. We report Global Burden of Disease (GBD) 2017 Study estimates on morbidity and mortality for all injuries.MethodsWe reviewed results for injuries from the GBD 2017 study. GBD 2017 measured injury-specific mortality and years of life lost (YLLs) using the Cause of Death Ensemble model. To measure non-fatal injuries, GBD 2017 modelled injury-specific incidence and converted this to prevalence and years lived with disability (YLDs). YLLs and YLDs were summed to calculate disability-adjusted life years (DALYs).FindingsIn 1990, there were 4 260 493 (4 085 700 to 4 396 138) injury deaths, which increased to 4 484 722 (4 332 010 to 4 585 554) deaths in 2017, while age-standardised mortality decreased from 1079 (1073 to 1086) to 738 (730 to 745) per 100 000. In 1990, there were 354 064 302 (95% uncertainty interval: 338 174 876 to 371 610 802) new cases of injury globally, which increased to 520 710 288 (493 430 247 to 547 988 635) new cases in 2017. During this time, age-standardised incidence decreased non-significantly from 6824 (6534 to 7147) to 6763 (6412 to 7118) per 100 000. Between 1990 and 2017, age-standardised DALYs decreased from 4947 (4655 to 5233) per 100 000 to 3267 (3058 to 3505).InterpretationInjuries are an important cause of health loss globally, though mortality has declined between 1990 and 2017. Future research in injury burden should focus on prevention in high-burden populations, improving data collection and ensuring access to medical care.
APA, Harvard, Vancouver, ISO, and other styles
8

Dr., Sakina Bouzekouk. "Burden of cardiovascular diseases in Qatar for main causes from 1990 to 2019." Singapore Journal of Cardiology 2, no. 2 (2021): 21–28. https://doi.org/10.5281/zenodo.7244427.

Full text
Abstract:
ABSTRACT Background: The Cardiovascular Diseases (CVD) burden keeps increasing worldwide remains unclear in many countries of the world including Qatar. The Global Burden of Disease (GBD) 2019 summarized and integrated available data on disease prevalence, incidence, and mortality to produce reliable estimates for cardiovascular burden. A detailed analysis of its time trend profile for Qatar is not available in the literature. In this research paper, relying on the reported data from the Global Burden Diseases Study findings between 1990 and 2019, a detailed analysis of the cardiovascular diseases patterns and their time changing between 1990 and 2019 is presented. Methods: Available data from the Global Burden of Disease (GBD) for Qatar from 1990 to 2019 in term of prevalence, mortality and disability adjusted Life-years (DALYs) caused by cardiovascular diseases (CVD) were analyzed to find out any prevailing disease pattern from 1990 to 2019. Major causes of CVDs in Qatar were analyzed on a single basis and given a special attention. Results: In 2019, there were an estimated 95,736.81cases of CVD (95% UI: 102,748.00 -89,160.69 cases) in Qatar. The prevalence rate increased from 2,694.58 (95% UI: 2,884.82-2,512.50) in 1990 to 3,342.13 per 100,000 (95% UI: 3,586.88- 3,112.56) in 2019 showing an increase of 19%. The number of deaths caused by CVD registered in 2019 were estimated to about 1,121.12 deaths (95% UI: 1,443.15 -854.75 against 367.58 cases (95% UI: (433.63-308.03) in 1990 while the death rate has decreased to 39.14 per 100, 000 (95% UI: 50.38- 29.84) in 2019 from an estimated value of 82.58 (95% UI: 97.42- 69.20) in 1990 showing a decrease of 52.6%. Ischemic heart disease was the leading cause of CVD in Qatar, followed by stroke. Conclusions: CVDs is still a main cause of health loss in Qatar as well as for the rest of the world. The major causes of deaths for CVD diseases in Qatar were found related to Ischemic heart diseases followed by Stroke which represent together more than 80.8% of the total CVD death rates for the year 2019. Compared to the global average, the age standardized DALYs rates in Qatar were higher. Even though a huge progress has been made, a comprehensive approach is required to prevent and alleviate the burden of CVD in Qatar. Regular updates of the GBD study is a useful guide for health professionals and policy makers in their efforts to reducing the overall burden of non-communicable disease and achieving specific global health targets for CVD in Qatar. Keywords: Cardiovascular disease; burden; Qatar; prevalence, mortality; DALYs.
APA, Harvard, Vancouver, ISO, and other styles
9

Tambunan, Ronald T. H. "ESTIMASI BEBAN GLOBAL SKABIES BERDASARKAN GLOBAL BURDEN OF DISEASE 2015." Majalah Ilmiah METHODA 10, no. 1 (2020): 16–30. http://dx.doi.org/10.46880/methoda.vol10no1.pp16-30.

Full text
Abstract:
Numerous population-based studies have documented high prevalence of scabies in overcrowded settings, particularly among children and in tropical regions. Thus, a research has done by Karimkhani et al. providing an estimate of the global burden of scabies using data from the Global Burden of Disease (GBD) study 2015. The methods that had been used in the research including identification scabies epidemiological data sources with a Bayesian meta-regression modelling tool, DisMod-MR 2.1, to yield prevalence estimates. Combination of prevalence estimates with a disability weight, measuring disfigurement, itch, and pain caused by scabies, to produce years lived with disability (YLDs). With an assumed zero mortality from scabies, YLDs were equivalent to disability-adjusted life-years (DALYs). They estimated DALYs from 195 countries divided into 21 world regions, in both sexes and 20 age groups, between 1990 and 2015. The findings showed that scabies was responsible 0.21% of DALYs from all conditions studied by GBD worldwide. The world regions of East Asia (age-standardised DALYs 136.32), Southeast Asia (134.57), Oceania (120.34), tropical Latin America (99.94), and south Asia (69.41) had the greatest burden of DALYs from scabies. Mean percent change of DALY rate from 1990 to 2015 was less than 8% in all world regions, except North America, which had a 23.9% increase. The five individual countries with greatest scabies burden were Indonesia (age-standardised DALYs 153.86), China (138.25), Timor-Leste (136.67), Vanuatu (131.59), and Fiji (130.91). The largest standard deviations of age-standardised DALYs between the 20 age groups were observed in Southeast Asia (60.1), Oceania (58.3) and East Asia (56.5), with the greatest DALY burdens in children, adolescents, and the elderly. It was concluded that the greatest burden of scabies is greater in tropical regions, especially in children, adolescents, and elderly people. As a worldwide epidemiological assessment, GBD 2015 provides broad and frequently updated measures of scabies burden in terms of skin effects. These global data might help guide research protocols and prioritisation efforts and focus scabies treatment and control measures.
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Jingjing, Dan Liu, Linan Zeng, et al. "Disease burden and risk factors of children aged 0–14 years in China: a retrospective study on data from the Global Burden of Disease Study 2019." BMJ Open 14, no. 5 (2024): e076013. http://dx.doi.org/10.1136/bmjopen-2023-076013.

Full text
Abstract:
ObjectivesThis study aimed to analyse the current status, trends and risk factors of disease burden from 1990 to 2019 among Chinese children.Design and participantsIt was a retrospective study on data from the Global Burden of Disease Study 2019 (GBD 2019). Data of disease burden and risk factors were extracted from the GBD 2019. Children were divided into two groups of <5 and 5–14 years. Data were analysed using GBD results query tool, Excel and Pareto analysis.Primary outcome measuresDisability-Adjusted Life Years (DALYs) and deaths.ResultsThe overall disease burden for both children <5 years and those aged 5–14 years significantly decreased from 1990 to 2019. For children aged <5 years, in 2019, the leading cause of deaths and DALYs were ‘neonatal disorders’, and the top risk factor was ‘low birth weight’. Compared with data of 1990, the ranking of causes of deaths and DALYs in 2019 saw the most significant increase for ‘HIV/AIDS and sexually transmitted infections’ and ‘skin and subcutaneous diseases’ respectively. Conversely, the ranking of deaths/DALYs causes that dropped most significantly was ‘nutritional deficiencies’. For children aged 5–14, in 2019, the leading deaths and DALYs causes were ‘unintentional injuries’ and ‘mental disorders’ respectively. The top risk factors were ‘alcohol use’ and ‘short gestation’, respectively. The ranking of deaths and DALYs causes rose most significantly were ‘HIV/AIDS and sexually transmitted infections’ and ‘neonatal disorders’, respectively. Conversely, the ranking of deaths causes that dropped most significantly were ‘other infectious diseases’, ‘enteric infections’ and ‘nutritional deficiencies’. For DALYs, the causes that dropped most significantly in ranking were ‘other infectious diseases’.ConclusionsThe disease burden of children has significantly changed from 1990 to 2019, with notable differences between children aged <5 and 5–14 years. To optimise the allocation of health resources, it is necessary to adjust management strategies based on the latest disease burden.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Global Burden of Disease (GBD) 2019"

1

Eyal, Nir, Samia A. Hurst, Christopher J. L. Murray, S. Andrew Schroeder, and Daniel Wikler, eds. Measuring the Global Burden of Disease. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190082543.001.0001.

Full text
Abstract:
In this volume, a group of leading philosophers, economists, epidemiologists, and policy scholars continue a twenty-year discussion of philosophical questions connected to the Global Burden of Disease Study (GBD), one of the largest-scale research collaborations in global health. Chapters explore issues in ethics, political philosophy, metaphysics, the philosophy of economics, and the philosophy of medicine. Some chapters identify previously unappreciated aspects of the GBD, including the way it handles causation and aggregates complex data while others offer fresh perspectives on frequently discussed topics such as discounting, age-weighting, and the valuation of health states. The volume concludes with a set of chapters discussing how epidemiological data should and shouldn’t be used.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Global Burden of Disease (GBD) 2019"

1

Yang, Gonghuan. "The GBD Study in China." In Commentary on the Global Burden of Disease Study. Springer Nature Singapore, 2025. https://doi.org/10.1007/978-981-96-5186-3_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stovner, Lars Jacob, Emma Nichols, Timothy J. Steiner, and Theo Vos. "Headache in the Global Burden of Disease (GBD) Studies." In Societal Impact of Headache. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-24728-7_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yang, Gonghuan. "Summary Measures of Population Health (SMPH) of the GBD Study: Disability-Adjusted Life Years (DALY) and Health-Adjusted Life Expectancy (HALE)." In Commentary on the Global Burden of Disease Study. Springer Nature Singapore, 2025. https://doi.org/10.1007/978-981-96-5186-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Widyasari, Vita, Ferry Fadzlul Rahman, and Valendryani Ningrum. "The Incidence and Prevalence of Stroke by Cause in Indonesia Based on Global Burden of Disease Study 2019." In Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021). Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-048-0_50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Terry, Robert Fraser, and Katherine Littler. "7 Research, Sample, and Data Sharing During Outbreaks, Pandemics, and Beyond." In Principles and Practice of Emergency Research Response. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-48408-7_9.

Full text
Abstract:
AbstractThe agreement at the time the human genome was first sequenced to release the data to the public domain set an example that encouraged other scientists doing other types of research to share their data freely to empower scientific discovery and minimize the burden of disease. There are still many barriers to data sharing, including how to ensure patient privacy, manage intellectual property, and reduce inequity in data reuse, with a one-way flow of raw data from less developed countries to wealthy countries and corporations that produce medical countermeasures that may first go to the highest bidder. In an era of increasing infectious disease outbreaks, ensuring the efficient exchange of research data is essential to expeditious response to emerging pathogens, especially in the urgent case of a potential or actual pandemic. This chapter will review principles of open access to research highlighted by the coronavirus disease 2019 (COVID-19) pandemic and current challenges to establishment of a global data-sharing system meeting the needs and interests of all the stakeholders, that is, every living human being.
APA, Harvard, Vancouver, ISO, and other styles
6

de Oliveira, Renata Savian Colvero, Grace T. Marcon Dal Sasso, Sriram Iyengar, and Harri Oinas-Kukkonen. "A Persuasive mHealth Application for Postoperative Cardiac Procedures: Prototype Design and Usability Study." In Communications in Computer and Information Science. Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-59091-7_6.

Full text
Abstract:
AbstractThe global burden of cardiovascular diseases (CVD) is a worldwide public health problem. In 2019, 18.6 million people died from CVD, representing a 17.1% increase compared to 2010. Also, some individuals who experience a cardiovascular event will require some form of cardiovascular procedure, such as a pacemaker or implantable cardioverter-defibrillator insertion, aneurysm repair, or heart valve replacement. Mobile health (mHealth) is a valuable tool for supporting individuals with CVD in self-management, providing medical recommendations, virtual consultations, reminders, and disease monitoring notifications. The main objective of this research was to enhance postoperative care for cardiac procedures. To achieve this, the research involved the development of a new mHealth application and the subsequent evaluation of its usability. The study constituted technological and usability research by using Design Science Research Methodology (DSRM). The design of the mobile application followed the principles of Persuasive Systems Design (PSD) model, which encompass a clear definition of the main task, user interaction through dialogue, system credibility, and social support, aiming to help change user behavior. The sample was non-probabilistic for convenience, and System Usability Scale (SUS) was applied to physicians and nurses as well as individuals in the information technology field. The sample comprised 18 participants, of whom 55.6% were female. The participants rated the application positively, with a median final SUS score of 95 (IQR 90–97.5). Finally, the mobile application presented high usability and user acceptance.
APA, Harvard, Vancouver, ISO, and other styles
7

Hausman, Daniel M. "Does GBD 2010 Succeed in Measuring Health?" In Measuring the Global Burden of Disease, edited by Nir Eyal, Samia A. Hurst, Christopher J. L. Murray, S. Andrew Schroeder, and Daniel Wikler. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190082543.003.0006.

Full text
Abstract:
This chapter responds to Joshua Salomon’s argument in Chapter 5 of this volume that the Global Burden of Disease 2010 (GBD) study succeeds in measuring health (Salomon et al. 2012a,b).. It begins by criticizing some detailed features of the GBD 2010’s surveys that make it unlikely that they succeed in measuring what they aim to measure. The chapter also comments on the consistency in the survey responses across very different nations, which may appear to support the claim that GBD 2010 succeeds in measuring health. Finally, the author argues that there is an interpretation of the results that is at least equally plausible, whereby GBD 2010 measures the values people assign to health rather than health itself.
APA, Harvard, Vancouver, ISO, and other styles
8

Ferrari, Alize J., Holly E. Erskine, Fiona J. Charlson, Damian F. Santomauro, Janni Leung, and Harvey A. Whiteford. "The global burden of mental and substance use disorders." In Oxford Textbook of Public Mental Health, edited by Dinesh Bhugra, Kamaldeep Bhui, Samuel Y. S. Wong, and Stephen E. Gilman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198792994.003.0004.

Full text
Abstract:
The Global Burden of Disease Study (GBD) uses a scientific framework to quantify health loss due to diseases, injuries, and risk factors by location, age, sex, and year. This work has been central in revealing the global health impacts of mental and substance use disorders. In this chapter, the global burden of mental and substance use disorders, based on findings from the Global Burden of Disease Study 2015 (GBD 2015), is presented. The methods used to estimate the burden of mental and substance use disorders and how that has evolved over time; the key analytical considerations for the accurate interpretation of burden findings; the accessibility of GBD data; and the applicability of GBD data in other areas of public health are summarized.
APA, Harvard, Vancouver, ISO, and other styles
9

Salomon, Joshua A. "Health Can Be Measured." In Measuring the Global Burden of Disease, edited by Nir Eyal, Samia A. Hurst, Christopher J. L. Murray, S. Andrew Schroeder, and Daniel Wikler. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190082543.003.0005.

Full text
Abstract:
This chapter defends the view that it is possible to measure the quantity of health and not simply the value of health and that the 2010 Global Burden of Disease Study (GBD) shows how this might be done. The author begins by offering a brief introduction to the GBD, focusing in particular on the evolution of measurement constructs and approaches pertaining to disability weights over the first several iterations of the GBD. The author then describes the new approach to disability weights measurement taken in the GBD 2010 study. Based on this, the chapter presents a conceptual framework and empirical evidence to support the claim that it is possible to measure quantities of health.
APA, Harvard, Vancouver, ISO, and other styles
10

Truelsen, Thomas, Catherine Johnson, Mohsen Naghavi, Theo Vos, Valery L. Feigin, and Gregory Roth. "Estimating the global burden of stroke." In Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology, edited by Carol Brayne, Valery L. Feigin, Lenore J. Launer, and Giancarlo Logroscino. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198749493.003.0041.

Full text
Abstract:
The Global Burden of Disease (GBD) study has provided global estimates on stroke since the 1990s. Estimates from the GBD are used to help appropriately plan and prioritize stroke care, prevention, and research activities in many countries. GBD 2015 represents the best and most consistent data for understanding the global burden of stroke, which remains a leading cause of death and disability. In this chapter we discuss current methods used to produce global and national estimates of health loss due to stroke, as well as challenges and future directions for population-level health metrics related to stroke.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Global Burden of Disease (GBD) 2019"

1

Marangoni, Igor Parada. "Hospital morbidity and mortality profile due to pneumonia in Brazil between 2010 and 2020." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-080.

Full text
Abstract:
Abstract Pneumonia is a lower respiratory tract infection that affected 489 million people worldwide in the year 2019 according to data from the Global Burden of Diseases (GBD) 2019 study,1,2. The disease was still responsible for over 2.49 million deaths in the year of the survey, surpassing other diseases such as tuberculosis and HIV, making pneumonia the leading infectious cause of death worldwide
APA, Harvard, Vancouver, ISO, and other styles
2

Ejaz, Taymmia, Muhammad Irfan, Javaid Ahmed Khan, et al. "The burden of Chronic Respiratory Diseases and attributable risk factors in Pakistan- A systematic analysis of global burden of disease study (GBD) 2019." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa467.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bhatt, P. S., H. Singh, C. Jani, et al. "Trends in Carbon Monoxide Morbidity and Mortality in the United States From 1990 to 2019 - an Observational Analysis Using the Global Burden of Disease (GBD) Database." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5394.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Molchanova, E., та A. Panchenko. "ПРИНЦИПЫ СТРАХОВАНИЯ И ОХРАНЫ ЗДОРОВЬЯ В РОССИИ И ФИНЛЯНДИИ". У Perspektivy social`no-ekonomicheskogo razvitiia prigranichnyh regionov 2019. Институт экономики - обособленное подразделение Федерального исследовательского центра "Карельский научный центр Российской академии наук", 2019. http://dx.doi.org/10.36867/br.2019.61.58.033.

Full text
Abstract:
Целью данной статьи является сравнительный анализ основных принципов страхования и охраны здоровья населения в России и Финляндии как ведущего направления социальноэкономической политики государства. Для достижения поставленной цели выполнена оценка эффективности функционирования национальных систем здравоохранения с помощью методики проекта Глобальное бремя болезней (ГББ) и индикатора потерянные годы здоровой жизни (DALY). Выявлены наиболее перспективные программы в области медико демографической политики, в том числе социальные инновации в сфере общественного здоровья. The purpose of this article is the comparative analysis of the basic principles of insurance and public health care in Russia and Finland as leading direction of social and economic policy of the state. For achievement of a goal assessment of efficiency of functioning of national health care systems by means of a project technique the Global Burden of Diseases (GBD) and the indicator disability adjusted life years (DALY) is executed. The most perspective programs in the field of medicopopulation policy, including social innovations in the sphere of public health are revealed.
APA, Harvard, Vancouver, ISO, and other styles
5

Wahidin, Mugi, Rini Febrianti, and Frides Susanty. "Burden of Cervical Cancer in Indonesia: Findings From the Global Burden of Disease Study 1990–2017." In 4th International Symposium on Health Research (ISHR 2019). Atlantis Press, 2020. http://dx.doi.org/10.2991/ahsr.k.200215.040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Liu, Xinyu. "The global burden of depressive disorder from 1990 to 2019: a systematic analysis for the global burden of disease study 2019." In International Conference on Biological Engineering and Medical Science (ICBIOMed2022), edited by Gary Royle and Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669550.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chen, H., Z. Zhou, K. MA, et al. "POS0381 GLOBAL, REGIONAL AND NATIONAL BURDEN OF COMORBIDITY FOR OSTEOARTHRITIS, 1990–2019: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.1685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kabir, Zubair, Kristina Kit, Eunan McKinney, and Sheila Gilheany. "P55 Attributable burden of alcohol harms in six nordic countries: a global burden of disease 2019 study." In Society for Social Medicine Annual Scientific Meeting Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jech-2022-ssmabstracts.148.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mehry, Shafiqa, Ahmed Raheem, Shaneela Khowaja, et al. "624 30 years trends of intentional injuries among women in Afghanistan, Pakistan, and India: findings from Global Burden of Disease (GBD) data." In 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/injuryprev-2024-safety.311.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cenderadewi, Muthia, Richard Franklin, and Susan Devine. "75 Informing unintentional drowning prevention in Indonesia: Global Burden of Disease 2019 Study." In 14th World Conference on Injury Prevention and Safety Promotion (Safety 2022) abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/injuryprev-2022-safety2022.25.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Global Burden of Disease (GBD) 2019"

1

Luo, Minjing, Yilin Li, Yingqiao Wang, et al. The Fragility of Statistically Significant Findings from Depression Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0086.

Full text
Abstract:
Review question / Objective: The Fragility of Statistically Significant Findings from Depression Randomized Controlled Trials. Condition being studied: Depression is a mental disorder characterized by a range of symptoms, including loss of memory and sleep, decreased energy, feelings of guilt or low mood, disturbed appetite, poor concentration, and an increased risk of suicide. According to a systematic analysis of the Global Burden of Disease Study 2019, depression is recognized as the leading cause of disease burden for mental disorders, accounting for the largest proportion of disability-adjusted life years (DALYs) at 37.3%. The fragility index (FI), which is the minimum number of changes from events to non-events resulting in loss of statistical significance, has been suggested as a means to aid the interpretation of trial results, as the potential inadequacy about robustness of threshold P-value as a tool for reporting binary outcomes in clinical trials. In this systematic review, we want to calculate the FI of randomized controlled trials (RCTs) in depression.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Global Burden of Disease (GBD) 2019' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography